PSP Research »

Insmed shares owned by PSP Research

Quarter-by-quarter ownership of Insmed (INSM) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $531k 3.0k 174.04

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Insmed

Vanguard Group
Darwin Global Management
BlackRock
FMR
Baker Bros. Advisors
State Street Corporation
Capital Research and Management Company - Division 3
Artisan Partners Limited Partnership
Rtw Investments
D. E. Shaw & Co
Geode Capital Management
Orbis Allan Gray
Norges Bank Investment Management
Franklin Resources
Invesco

View all funds holding Insmed